Rising Star: King & Spalding's Robert Friedman
Robert Friedman was at the forefront of King & Spalding LLP's defense of GlaxoSmithKline PLC and its embattled antidepressant Paxil in 2010, coordinating defensive discovery across hundreds of suits in state...To view the full article, register now.
Already a subscriber? Click here to view full article